Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features

被引:0
|
作者
R. Mantegazza
P. Bernasconi
Paolo Confalonieri
Ferdinando Cornelio
机构
[1] Department of Neuromuscular Diseases,
[2] “C. Besta” National Neurological Institute,undefined
[3] Via Celoria 11,undefined
[4] I-20133 Milan,undefined
[5] Italy Tel.: +39-2-2394282,undefined
[6] Fax: +39-2-70633874,undefined
[7] e-mail: mantega@imiucca.csi.unimi.it,undefined
来源
Journal of Neurology | 1997年 / 244卷
关键词
Key words Inflammatory; myopathies; Autoimmunity; Muscle; Collagen vascular diseases; Malignancies;
D O I
暂无
中图分类号
学科分类号
摘要
The inflammatory myopathies are a heterogeneous group of muscle diseases characterized by muscle degeneration mediated by inflammatory processes. They may be idiopathic, as in polymyositis, dermatomyositis and inclusion body myositis, or associated with systemic disorders such as malignancies, overlap syndromes, and retroviral infection. The pathogenesis of each disease is discussed together with more recent molecular and cellular immunology findings. Salient diagnostic, clinical and pharmacological features are also reviewed.
引用
收藏
页码:277 / 287
页数:10
相关论文
共 50 条
  • [31] Differential Immunohistological Features of Inflammatory Myopathies and Dysferlinopathy
    Choi, Jae-Hwan
    Park, Yeong-Eun
    Kim, Sung-Il
    Kim, Jeong-Il
    Lee, Chang-Hoon
    Park, Kyu-Hyun
    Kim, Dae-Seong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (06) : 1015 - 1023
  • [32] MYOPATHIES ASSOCIATED WITH SYSTEMIC SCLEROSIS: CLINICAL AND IMMUNOLOGICAL FEATURES FROM A TERTIARY CENTRE COHORT
    Nichitean, R.
    Mociran, A.
    Szabo, I.
    Damian, L.
    Felea, I.
    Siao-Pin, S.
    Rednic, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1285 - 1285
  • [33] Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
    Grundtman, Cecilia
    Malmstroem, Vivianne
    Lundberg, Ingrid E.
    ARTHRITIS RESEARCH & THERAPY, 2007, 9 (02)
  • [34] Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
    Cecilia Grundtman
    Vivianne Malmström
    Ingrid E Lundberg
    Arthritis Research & Therapy, 9
  • [35] IDIOPATHIC INFLAMMATORY MYOPATHIES - CLINICAL ASPECTS
    BYRNE, E
    DENNETT, X
    BAILLIERES CLINICAL NEUROLOGY, 1993, 2 (03): : 499 - 526
  • [36] Clinical Evaluation and Management of Inflammatory Myopathies
    Chhibber, Sameer
    Amato, Anthony A.
    SEMINARS IN NEUROLOGY, 2015, 35 (04) : 347 - 359
  • [37] Clinical presentation of the idiopathic inflammatory myopathies
    Yazici, Y
    Kagen, LJ
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (04) : 823 - +
  • [38] Review: An update on inflammatory and autoimmune myopathies
    Dalakas, M. C.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 (03) : 226 - 242
  • [39] Idiopathic inflammatory myopathies. A review
    Acosta, Ignacio
    Manuel Matamala, Jose
    Jara, Paula
    Pino, Francisca
    Gallardo, Alejandra
    Verdugo, Renato
    REVISTA MEDICA DE CHILE, 2019, 147 (03) : 342 - 355
  • [40] Rituximab in the treatment of inflammatory myopathies: a review
    Fasano, Serena
    Gordon, Patrick
    Hajji, Raouf
    Loyo, Esthela
    Isenberg, David A.
    RHEUMATOLOGY, 2017, 56 (01) : 26 - 36